Stock data
Palvella Therapeutics, Inc. (PVLA)
Palvella Therapeutics, Inc. (PVLA) reported net income of -US$41.72M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$38.60M | -US$41.72M | — |
| 2024 | — | — | -US$14.10M | -US$17.43M | — |
| 2023 | US$42.81M | — | -US$11.87M | US$18.69M | — |
| 2022 | US$25.90M | — | -US$43.47M | -US$33.28M | — |
| 2021 | US$31.42M | — | -US$51.83M | -US$45.74M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$21.87M | — |
| 2026-03-31 | — | -US$15.77M | — |
| 2025-12-31 | — | -US$12.71M | — |
| 2025-09-30 | — | -US$11.35M | — |
| 2025-06-30 | — | -US$9.47M | — |
| 2025-03-31 | — | -US$8.19M | — |
| 2024-12-31 | — | -US$3.95M | — |
| 2024-09-30 | US$0.00M | -US$6.78M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.